Author

Larissa Agapova

Director, Stem Cell Biology, ISCO - Cited by 2,623 - Cell Biology - Cell Therapy

Biography

Dilip Kumar Jaiswal, belonging to International Stem Cell Corporation, Carlsbad CA 92008. Interested in the field of Cancer Biology, Flow Cytometry.                                                      
Title
Cited by
Year
The antioxidant function of the p53 tumor suppressor
AA Sablina, AV Budanov, GV Ilyinskaya, LS Agapova, JE Kravchenko, ...Nature medicine 11 (12), 1306-1313, 2005200
1291
2005
Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway
JE Kravchenko, GV Ilyinskaya, PG Komarov, LS Agapova, DV Kochetkov, ...Proceedings of the National Academy of Sciences 105 (17), 6302-6307, 2008200
233
2008
HLA homozygous stem cell lines derived from human parthenogenetic blastocysts
ES Revazova, NA Turovets, OD Kochetkova, LS Agapova, JL Sebastian, ...Cloning and stem cells 10 (1), 11-24, 2008200
182
2008
Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability
PB Kopnin, LS Agapova, BP Kopnin, PM ChumakovCancer research 67 (10), 4671-4678, 2007200
169
2007
p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway
NV Khromova, PB Kopnin, EV Stepanova, LS Agapova, BP KopninCancer letters 276 (2), 143-151, 2009200
113
2009
Activation of p53-mediated cell cycle checkpoint in response to micronuclei formation
AA Sablina, GV Ilyinskaya, SN Rubtsova, LS Agapova, PM Chumakov, ...Journal of cell science 111 (7), 977-984, 1998199
95
1998
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells
LS Agapova, BV Chernyak, LV Domnina, VB Dugina, AY Efimenko, ...Biochemistry (Moscow) 73, 1300-1316, 2008200
93
2008
Chromosome changes caused by alterations of p53 expression
LS Agapova, GV Ilyinskaya, NA Turovets, AV Ivanov, PM Chumakov, ...Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 354 (1 …, 1996199
74
1996
P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints
LS Agapova, AV Ivanov, AA Sablina, PB Kopnin, OI Sokova, ...Oncogene 18 (20), 3135-3142, 1999199
59
1999
p53 does not control the spindle assembly cell cycle checkpoint but mediates G1 arrest in response to disruption of microtubule system
AA Sablina, LS Agapova, PM Chumakov, BP KopninCell biology international 23 (5), 323-334, 1999199
48
1999
Многоликий р53: разнообразие форм, функций, опухольсупрессирующих и онкогенных активностей
BP Kopnin, PB Kopnin, NV Khromova, LS AgapovaКлиническая онкогематология. Фундаментальные исследования и клиническая …, 2008200
47
2008
Derivation of human parthenogenetic stem cell lines
N Turovets, A Semechkin, L Kuzmichev, J Janus, L Agapova, E RevazovaHuman Pluripotent Stem Cells: Methods and Protocols, 37-54, 2011201
30
2011
Activation of Ras-Ral pathway attenuates p53-independent DNA damage G2 checkpoint
LS Agapova, JL Volodina, PM Chumakov, BP KopninJournal of Biological Chemistry 279 (35), 36382-36389, 2004200
30
2004
Equivalence of conventionally-derived and parthenote-derived human embryonic stem cells
JV Harness, NA Turovets, MJ Seiler, G Nistor, G Altun, LS Agapova, ...PloS one 6 (1), e14499, 2011201
27
2011
Derivation of high-purity definitive endoderm from human parthenogenetic stem cells using an in vitro analog of the primitive streak
N Turovets, J Fair, R West, A Ostrowska, R Semechkin, J Janus, L Cui, ...Cell transplantation 21 (1), 217-234, 2012201
19
2012
Retroviral reporter systems for assessing the activity of stress-inducible signal transduction pathways controlled by the p53, HIF-1, and HSF-1 transcription factors
OV Razorenova, LS Agapova, AV Budanov, AV Ivanov, SM Strunina, ...Molecular Biology 39, 253-259, 2005200
17
2005
Multifaced р53: variety of forms, functions, tumor-suppressive and oncogenic activities
BP Kopnin, PB Kopnin, NV Khromova, LS AgapovaКлиническая онкогематология. Фундаментальные исследования и клиническая …, 2008200
16
2008
Effect of inactivating the p33ING1 tumor suppressor on the function of cell cycle" checkpoints" and genome stability
NA Turovets, LS Agapova, PB Kopnin, NM Tulina, PM Chumakov, ...Genetika 36 (3), 385-392, 2000200
11
2000
31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016
C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ...Journal for ImmunoTherapy of Cancer 4, 7-221, 2016201
10
2016
Inactivation of p33ING1 tumor suppressor affects the function of the cell cycle "checkpoints" and stability of the genome
NA Turovets, LS Agapova, BP Kopnin, PB Kopnin, NM Tulina, ...Russian Journal of Genetics 36 (3), 305-312, 2000200
7
2000

Referred From: https://scholar.google.ru/citations?user=EHcXJ3wAAAAJ&hl=en

Cited by
Citations 2623
h-index 17
i10-index 21
Recommended Journals
Open Access Journals